Biotechnology Initiatives: India's Progress and Policies

Early Foundations and Growth

India recognized the potential of biotechnology early on. The National Biotechnology Board (NBTB) was established in 1982 under the Department of Science & Technology. This board aimed to promote research and development in biotechnology across various sectors. Its success led to the formation of a dedicated department. In 1986, the Department of Biotechnology (DBT) was created under the Ministry of Science & Technology. This marked a significant step, providing a focused approach to policy formulation, promotion of R&D, and creation of infrastructure. The DBT's mandate includes developing human resources, setting up centers of excellence, and fostering international collaborations. These early initiatives laid the groundwork for India's current robust biotechnology ecosystem, supporting both basic and applied research.

Key Policy Frameworks

Several policy frameworks have guided India's biotechnology sector. The National Biotechnology Development Strategy (NBDS) was first launched in 2007. It aimed to make India a global leader in biotechnology. The strategy focused on areas like agricultural biotechnology, healthcare biotechnology, industrial biotechnology, and environmental biotechnology. It also emphasized human resource development, infrastructure creation, and regulatory reforms. A revised National Biotechnology Development Strategy (NBDS-II) was launched in 2015. This updated strategy aimed to achieve a USD 100 billion bio-economy by 2025. It focused on translational research, public-private partnerships, and skill development. These strategies provide a roadmap for accelerating growth and innovation in the biotechnology sector, addressing societal challenges through scientific advancements.

Major Government Schemes

The Indian government has launched several schemes to boost biotechnology. The Biotechnology Industry Research Assistance Council (BIRAC) was set up in 2012 by the DBT. BIRAC aims to empower and enable the biotech innovation ecosystem. It provides strategic research and innovation funding to start-ups and SMEs. Another important initiative is the National Biopharma Mission, launched in 2017. This mission, also known as Innovate in India (i3) program, aims to accelerate the development of biopharmaceuticals. It focuses on vaccines, biologics, and medical devices. The mission is partly funded by the World Bank. Additionally, the Bio-Tech KISAN (Krishi Innovation Science Application Network) scheme connects farmers with scientists. It aims to understand farmers' challenges and provide scientific solutions, especially for women farmers. These schemes are crucial for translating research into products and services.

Infrastructure and Human Resources

Developing robust infrastructure and skilled human resources is vital for biotechnology. The DBT has established several autonomous institutions and centers of excellence across the country. Examples include the National Institute of Immunology (NII) in Delhi, the Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad, and the National Centre for Cell Science (NCCS) in Pune. These institutions conduct cutting-edge research and provide advanced training. The government also supports various fellowship programs like the Ramalingaswami Re-entry Fellowship and the DBT-Wellcome Trust India Alliance. These programs attract and retain talented scientists. Furthermore, initiatives like the Skill Development Program in Biotechnology aim to create a skilled workforce for the industry. These efforts ensure a continuous supply of trained professionals and world-class research facilities.

Regulatory Frameworks and Ethics

Effective regulation is essential for safe and ethical biotechnology development. The Genetic Engineering Appraisal Committee (GEAC) operates under the Ministry of Environment, Forest and Climate Change. It is responsible for approving activities involving large-scale use of hazardous microorganisms and recombinants in research and industrial production. GEAC also approves the release of genetically engineered organisms into the environment, including genetically modified (GM) crops. The Indian Council of Medical Research (ICMR) provides guidelines for biomedical research involving human subjects. Ethical considerations are paramount in areas like gene editing and stem cell research. India is also a signatory to international agreements like the Cartagena Protocol on Biosafety. These regulatory bodies and ethical guidelines ensure responsible development and application of biotechnology, balancing innovation with safety and societal well-being.

Important Keywords Explained

Department of Biotechnology (DBT)organization

Established in 1986 under the Ministry of Science & Technology, DBT is the nodal agency for promoting biotechnology research and development in India. It formulates policies, funds R&D projects, develops human resources, and creates infrastructure for the biotech sector. Its mandate covers diverse areas from agriculture to healthcare.

BIRACorganization

Biotechnology Industry Research Assistance Council (BIRAC) is a Public Sector Undertaking established by the DBT in 2012. It acts as an interface agency to strengthen and empower the emerging biotechnology enterprise in India. BIRAC provides strategic funding and support to start-ups, SMEs, and academic institutions for innovation and product development.

GEACorganization

The Genetic Engineering Appraisal Committee (GEAC) is the apex body under the Ministry of Environment, Forest and Climate Change. It is responsible for the appraisal of activities involving large-scale use of hazardous microorganisms and recombinants in research and industrial production. GEAC also approves the environmental release of genetically engineered organisms, including GM crops.

National Biopharma Missionscheme

Also known as the Innovate in India (i3) program, this mission was launched in 2017 by the DBT. It aims to accelerate the discovery and development of biopharmaceutical products in India. The mission focuses on key areas like vaccines, biologics, and medical devices, with partial funding from the World Bank, to strengthen the biopharmaceutical industry.

Additional Facts & Context

• India is among the top 12 biotechnology destinations globally.
• The Indian bio-economy was estimated at over USD 80 billion in 2021.
• Over 5,000 biotech start-ups are supported by BIRAC.
• India has over 1,000 biotech companies.
• The National Biopharma Mission has a total cost of USD 250 million.